[Skip to Content]
[Skip to Content Landing]
October 1978

Malignant Melanoma

Arch Dermatol. 1978;114(10):1551. doi:10.1001/archderm.1978.01640220092028

To the Editor.—  An editorial in the March issue of the Archives (114:369-370, 1978) frequently refers to our article, "Malignant Melanoma: A Review."` The authors of this editorial state that they "... have written this communication to briefly emphasize those facets of the article [which they] consider most important." We have no objection to a summary of our article except when the summary is in error. As the editorial was published, it stated: "The therapy of disseminated melanoma remains discouraging, as evidenced by the poor survival of stage 1 and 2 patients." This is a confusing statement since the survival rate of patients with stage 1 melanoma is now very good (approaching 70% to 80% in some recently published series). Correspondence from Dr Callen indicates that their original manuscript referred to stage 2 and 3 patients.The authors of the editorial write that we did not discuss immunology or immunotherapy of

First Page Preview View Large
First page PDF preview
First page PDF preview